- Home
- PM vs AZN Comparison
PM vs AZN Comparison
Compare PM & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PM
- AZN
- Stock Information
- Founded
- PM 1987
- AZN 1992
- Country
- PM United States
- AZN United Kingdom
- Employees
- PM N/A
- AZN N/A
- Industry
- PM Medicinal Chemicals and Botanical Products
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- PM Health Care
- AZN Health Care
- Exchange
- PM Nasdaq
- AZN Nasdaq
- Market Cap
- PM 251.5B
- AZN 252.9B
- IPO Year
- PM N/A
- AZN 1993
- Fundamental
- Price
- PM $162.08
- AZN $76.88
- Analyst Decision
- PM Strong Buy
- AZN Strong Buy
- Analyst Count
- PM 12
- AZN 1
- Target Price
- PM $178.25
- AZN N/A
- AVG Volume (30 Days)
- PM 5.2M
- AZN 3.4M
- Earning Date
- PM 10-21-2025
- AZN 11-11-2025
- Dividend Yield
- PM 3.25%
- AZN 1.98%
- EPS Growth
- PM N/A
- AZN 28.86
- EPS
- PM 5.27
- AZN 5.31
- Revenue
- PM $39,058,000,000.00
- AZN $56,501,000,000.00
- Revenue This Year
- PM $11.48
- AZN $10.57
- Revenue Next Year
- PM $8.40
- AZN $6.25
- P/E Ratio
- PM $31.55
- AZN $14.63
- Revenue Growth
- PM 7.16
- AZN 15.00
- 52 Week Low
- PM $116.12
- AZN $61.24
- 52 Week High
- PM $186.69
- AZN $82.41
- Technical
- Relative Strength Index (RSI)
- PM 44.52
- AZN 40.09
- Support Level
- PM $161.43
- AZN $80.58
- Resistance Level
- PM $167.08
- AZN $78.08
- Average True Range (ATR)
- PM 3.61
- AZN 1.00
- MACD
- PM 0.07
- AZN -0.75
- Stochastic Oscillator
- PM 30.95
- AZN 13.36
About PM Philip Morris International Inc
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokable products but also gained a toehold in the US to sell its Iqos heated tobacco product.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.